about
Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of PoxvirusesThe α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppressionGlycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.The secret life of viral entry glycoproteins: moonlighting in immune evasion.A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization.O-linked glycosylation of the mucin domain of the herpes simplex virus type 1-specific glycoprotein gC-1 is temporally regulated in a seed-and-spread mannerA strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1Bovine herpesvirus type 4 glycoprotein L is nonessential for infectivity but triggers virion endocytosis during entry.Multiple Novel Functions of Henipavirus O-glycans: The First O-glycan Functions Identified in the Paramyxovirus FamilyThe Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected CellsProteomic characterization of bovine herpesvirus 4 extracellular virions.Bovine Herpesvirus 4 Modulates Its β-1,6-N-Acetylglucosaminyltransferase Activity through Alternative SplicingRational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding SiteGlobal Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases.The Major Envelope Glycoprotein of Murid Herpesvirus 4 Promotes Sexual Transmission.Primary replication and invasion of the bovine gammaherpesvirus BoHV-4 in the genital mucosae.
P2860
Q26797325-F3A748EE-C9FE-4C8A-AE06-CBB034FE4B9AQ27312735-93F02348-7789-4A9B-8500-6B7576CB125EQ34468958-7815A7DF-F473-4DA8-AA22-0E41E437FC8BQ34733547-F9D55CD5-15F9-40BE-928B-844E5B82ED3CQ35034283-C9638359-5DD4-453C-93B4-BF934667FE94Q35104007-74014E01-439C-4E21-9CD5-9EB564AB6704Q35242303-5C01C5E9-2704-4EBE-B459-D8712A2B0785Q35826131-5F6871B7-C3C3-46CB-8942-D8EACFA6DB01Q35921009-EBBE6B19-4DA7-466D-8A24-8EAF86F9966CQ35989470-AD3062EC-8AC6-4648-8B2E-3D2064E203A2Q36363307-FB4A94AB-7571-4E35-A0A8-27EFE49CA843Q36524008-CB4CC20C-8AB1-46A1-940A-2256669417D9Q36590540-39B2D313-B241-4424-A027-F728A6F91CA4Q37065966-37F8C7C6-2D54-4C99-A040-14F48339DED1Q39203410-BA1CE601-CCD0-4BF0-A703-DE23F29F9A3EQ40235615-66835756-CCAD-4F0F-BAB5-C3716597BE12Q47114380-57CE5D95-537C-4FF6-984E-F4A84497087F
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antibody evasion by a gammaherpesvirus O-glycan shield
@ast
Antibody evasion by a gammaherpesvirus O-glycan shield
@en
Antibody evasion by a gammaherpesvirus O-glycan shield
@nl
type
label
Antibody evasion by a gammaherpesvirus O-glycan shield
@ast
Antibody evasion by a gammaherpesvirus O-glycan shield
@en
Antibody evasion by a gammaherpesvirus O-glycan shield
@nl
prefLabel
Antibody evasion by a gammaherpesvirus O-glycan shield
@ast
Antibody evasion by a gammaherpesvirus O-glycan shield
@en
Antibody evasion by a gammaherpesvirus O-glycan shield
@nl
P2093
P2860
P1433
P1476
Antibody evasion by a gammaherpesvirus O-glycan shield
@en
P2093
Antoine Guillaume
Bénédicte Machiels
Céline Lété
Laurent Gillet
Philip G Stevenson
P2860
P304
P356
10.1371/JOURNAL.PPAT.1002387
P577
2011-11-17T00:00:00Z